Literature DB >> 3202237

Heterogeneity of proteins in commercial preparations of human chorionic gonadotropin (hCG) demonstrated by Western blotting.

J H Morse1, J W Lustbader, J W Harrington, R E Canfield.   

Abstract

Immunoblotting has been utilized to detect the presence of human chorionic gonadotropin (hCG), its alpha and beta subunits, the Tamm-Horsfall protein (uromodulin), immunoglobulins G (IgG) and M (IgM), kappa (K) and lambda (L) chains, and serum albumin in commercially available preparations of hCG intended for human use. Concentrated pregnancy, postpartum, and normal urines were studied as a comparison. Those hCG batches prepared from pooled first-trimester pregnancy urine contained all of the hCG and non-hCG proteins listed above or their fragments, with the single exception of the IgM mu chain. The conflicting literature regarding the immunomodulatory properties of hCG requires reevaluation, since many previous reports of immunologic activity utilized these preparations, containing intact and degraded IgG, K, and L chains, and the Tamm-Horsfall protein, all of which may contribute to an altered immune response. Since hCG can be prepared in high yields, free of these contaminants, these data suggest that patients are being unnecessarily exposed to contaminating substances when receiving parenteral injections of hCG.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202237     DOI: 10.1111/j.1600-0897.1988.tb00217.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol Microbiol        ISSN: 8755-8920


  2 in total

1.  Phase III trial comparing the efficacy and safety of recombinant- or urine-derived human chorionic gonadotropin for ovulation triggering in Japanese women diagnosed with anovulation or oligo-ovulation and undergoing ovulation induction with follitropin-alfa.

Authors:  Hideyuki Ikenaga; Yudai Tanaka; Masahide Shiotani; Daniela Rogoff; Shin Shimizu; Osamu Ishihara; Yoshiaki Sato; Yoshiharu Morimoto; Aisaku Fukuda; Kohzo Aisaka; Koji Yoshida; Naoki Hayashi; Hirotsugu Oku; Yuji Abe; Atsushi Haruki; Motoharu Ishikawa; Takeshi Kuramoto
Journal:  Reprod Med Biol       Date:  2016-12-04

2.  Comparative Pharmacokinetics, Bioequivalence and Safety Study of Two Recombinant Human Chorionic Gonadotropin Injections in Healthy Chinese Subjects.

Authors:  Jin Wang; Tianli Yang; Hekun Mei; Xueming Yu; Hongmei Peng; Rui Wang; Yun Cai
Journal:  Drug Des Devel Ther       Date:  2020-01-29       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.